Profound Medical Corp. (PRN)
TSX
Closed
Aug 25, 2026
Day's Range
9.3152 wk Range
5.23Overview - PRN - Profound Medical Corp.
Key Statistics
Valuation
Enterprise Value
434.24M
P/E (Trailing)
‪-6.68‬
P/E (Forward)
‪-11.57‬
PEG Ratio
‪0.13‬
Price / Sales (TTM)
‪18.10‬
Price / Book
‪4.12‬
EV / EBITDA
‪-9.04‬
Profitability
Gross Margin
‪78.41%‬
Profit Margin
‪-171.56%‬
Operating Margin
‪-445.67%‬
Return on Assets
‪-39.45%‬
Return on Equity
‪-73.52%‬
Ownership
Shares Outstanding
36.33M
Float
35.53M
Short % of Shares Outstanding
‪0.98%‬
Held by Insiders
‪4.08%‬
Held by Institutions
‪45.25%‬
Price stats
Beta
‪0.52‬
50-Day Avg
‪9.86‬
200-Day Avg
‪9.52‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
5 analysts
Market Cap - PRN - Profound Medical Corp.
Peers - PRN - Profound Medical Corp.
Peer Comparison
Compared with companies in Medical Devices listed on TSX.
Profile Summary - PRN - Profound Medical Corp.
About
Profound Medical Corp. is a pioneering company in the medical technology sector, specializing in the development of innovative therapeutic platforms for treating prostate issues, breast cancer, and uterine fibroids. The core function of Profound Medical Corp. is to provide minimally invasive therapeutic solutions,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
